ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "pregnancy and thrombosis"

  • Abstract Number: 157 • 2018 ACR/ARHP Annual Meeting

    Identifying Additional Risk Factors Associated with Thrombosis and Pregnancy Morbidity in a Unique Cohort of Antiphospholipid Antibody Positive Chinese Patients

    Yu Zuo1, Chun Li2, Song Zhang3, Una Makris1, David Karp4 and Zhan-Guo Li5, 1University of Texas Southwestern Medical Center, Dallas, TX, 2Peking University People's Hospital, Beijing, China, 3University of Texas Southwestern Medical Center, dallas, TX, 4Rheumatology, UT Southwestern Med Ctr, Dallas, TX, 5Rheum/Immunology, Peking University People's Hospital, Beijing, China

    Background/Purpose: Risk stratification of asymptomatic aPL carriers is difficult. Our objective was to identify additional clinical and epidemiological predictors of arterial thrombosis, venous thrombosis, and…
  • Abstract Number: 2 • 2017 ACR/ARHP Annual Meeting

    Identifying “Second Hit” Risk Factor(s) Associated with Thrombosis and Pregnancy Morbidity in Ethnically Diverse Antiphospholipid Antibodies Positive Patients

    Yu Zuo1, Jennifer Fan2, Ravi Sarode1, Song Zhang2, Una E. Makris1, David Karp3 and Yu-min Shen2, 1University of Texas Southwestern Medical Center, Dallas, TX, 2University of Texas Southwestern Medical Center, dallas, TX, 3Rheumatology, UT Southwestern Med Ctr, Dallas, TX

    Background/Purpose: The evaluation of thrombotic and pregnancy risks associated with antiphospholipid antibodies (aPL) in individual patients without APS clinical manifestation is challenging. Our aim is…
  • Abstract Number: 2762 • 2017 ACR/ARHP Annual Meeting

    Study of 60 Patients with Intrauterine Fetal Deaths Related to Antiphospholipid Syndrome

    Mériem Belhocine1, Laetitia Coutte2, Nicolas Martin Silva3, Nathalie Morel4, Gaelle Guettrot-Imbert4, Romain Paule4, Michel Dreyfus5, Micaela Fredi6, Odile Souchaud-Debouverie7, Jean Charles Piette8, Veronique Le Guern4 and Nathalie Costedoat-Chalumeau1, 1Service de médecine interne Pôle médecine, Hôpital Cochin, Centre de référence maladies auto-immunes et systémiques rares de l’île de France, Paris, France, 2Department of Internal Medicine, Department of Internal Medicine, Cochin University Hospital, paris, France, 3Department of Internal Medicine, Department of Internal Medicine, University Hospital Center of Caen, Caen, France, 4Department of Internal Medicine, Department of Internal Medicine, Cochin University Hospital, Paris, France, 5Department of Gynecology and Obstetrics, Department of Gynecology and Obstetrics, University Hospital Center of Caen, Caen, France, 6Department of Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, 7Department of Internal Medicine, Department of Internal Medicine, Poitiers University Hospital, Poitiers, France, 8Department of Internal Medicine, Department of Internal Medicine, University Hospital Pitié-Salpétrière, Paris, France

    Background/Purpose: The antiphospholipid syndrome (APS) is defined by a combination of arterial and/or venous thrombosis, pregnancy morbidity, and persistent antiphospholipid antibodies. There is a real…
  • Abstract Number: 2198 • 2015 ACR/ARHP Annual Meeting

    Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking Clinical Database and Repository Analysis: Determinants of Thrombosis in Patients Presenting with Obstetric APS

    Guilherme Ramires de Jesus1, STEPHANE ZUILY2, Doruk Erkan3, Roger A. Levy4 and on Behalf of APS ACTION, 1Department of Obstetrics, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 2CHU de Nancy, Regional Competence Centre For Rare Vascular And Systemic Autoimmune Diseases, Vascular Medicine Division, NANCY, France, 3Rheumatology, Hospital for Special Surgery, New York, NY, 4Rheumatology, Department of Rheumatology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

    Background/Purpose: APS ACTION Clinical Database and Repository (“Registry”) was created to study the natural course of disease over 10 years in persistently antiphospholipid antibody (aPL)-positive…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences